Previous close | 94.79 |
Open | 86.00 |
Bid | 83.00 x 26200 |
Ask | 86.00 x 26000 |
Day's range | 86.00 - 86.00 |
52-week range | 78.32 - 119.42 |
Volume | |
Avg. volume | 77 |
Market cap | 13.176B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 23.06 |
EPS (TTM) | 3.73 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 132.31 |
Novavax signs a $1.2 billion licensing deal with France’s Sanofi, guidance from Akamai Technologies misses estimates, and SoundHound stock surges after first-quarter revenue jumps 73%.
Insightful Analysis of Akamai Technologies Inc's Strengths, Weaknesses, Opportunities, and Threats
The headline numbers for Akamai Technologies (AKAM) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.